SCHEMBL6709150

SCHEMBL6709150

Cn1c(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc2cccc(NC(=O)N3CCOCC3)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.42
KDM4E B2RXH2 2/20 0.39
HSD17B10 Q99714 2/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
BACE1 P56817 6/20 0.38
RAB9A P51151 2/20 0.36
HIF1A Q16665 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
MTOR P42345 1/20 0.34
POLB P06746 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
DGAT1 O75907 1/20 0.34
NPC1 O15118 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
AAK1 Q2M2I8 1/20 0.33
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713517 0.91 ALDH1A1 (0.39) MAPTKDM4EHSD17B10ALDH1A1TSHR
SCHEMBL6713278 0.89 HSD17B10 (0.38) MAPTKDM4EHSD17B10ALDH1A1TSHR
SCHEMBL6710075 0.85 MAPT (0.42) MAPTKDM4EHSD17B10ALDH1A1TSHR
SCHEMBL6711760 0.85 ALB (0.53) KDM4EALDH1A1POLBMEN1KMT2A
SCHEMBL6710547 0.85 GRM4 (0.41) MAPTRAB9AHIF1ANPSR1RXFP1
SCHEMBL6708968 0.83 HIF1A (0.41) RAB9AHIF1ANPSR1RXFP1KMT2A
SCHEMBL6711867 0.83 HIF1A (0.37) ALDH1A1HIF1ANPSR1RXFP1KMT2A
SCHEMBL6713815 0.83 HIF1A (0.41) HIF1ANPSR1RXFP1KMT2ALMNA
SCHEMBL6711753 0.81 HPGD (0.41) KDM4EHSD17B10ALDH1A1RAB9ARXFP1
SCHEMBL6710170 0.81 NPSR1 (0.43) KDM4EALDH1A1BACE1HIF1ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 MAPT 4754/4885KDM4E 1582/4885HSD17B10 1990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.